UNSPSC 85818704: Transfusion of autologous factor ix into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous factor ix into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263W0

UNSPSC 85818704 Transfusion of autologous factor ix into central artery, percutaneous approach is a Commodity code that shows little relevant recent activity under state and local procurement. The recent opportunities tagged with this code do not involve the clinical procedure it names. Instead, the opportunities represent a broad mix of health services procurement — disability medical evaluations, surgical benefit administration, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing — none of which map to the specific transfusion procedure the code describes. The mismatch suggests the code has been applied inconsistently or inappropriately by the issuing bodies, or the source data contains tagging errors that obscure actual spending patterns under this Commodity code.

The opportunities that do appear span state departments, county health systems, and municipal retirement offices across Arizona, California, Florida, and Washington. The City of Phoenix Retirement Office issued an RFP for independent medical evaluation services (due October 16, 2026) supporting disability determinations for public safety personnel; the City of Long Beach issued an RFP for surgical benefit carve-out administration through Centers of Excellence (due October 7, 2026); the Washington State Department of Transportation requested occupational medical surveillance services across 14 statewide ferry locations (due October 9, 2026); and the County of Santa Clara Health System sought temporary health professional staffing (due October 7, 2026). The geographic spread and issuing-body diversity suggest active state and local health procurement, but without recent solicitations that clearly target the autologous factor ix transfusion procedure itself, this Commodity code warrants careful vetting before pursuit.